-
1
-
-
0033972180
-
The HLA crossroad in tumorimmunology//Hum
-
P
-
Algarra I., Cabrera T., Garrido F. The HLA crossroad in tumorimmunology//Hum. Immunol. - 2000. - Vol. 61. - P. 65-73.
-
(2000)
Immunol
, vol.61
, pp. 65-73
-
-
Algarra, I.1
Cabrera, T.2
Garrido, F.3
-
2
-
-
47249133603
-
-
An International System for Human Cytogenetic Nomenclature // Ed. F.Mitelman, S.Karger - Basel: Memphis, USA, 1995. - 114 p.
-
An International System for Human Cytogenetic Nomenclature // Ed. F.Mitelman, S.Karger - Basel: Memphis, USA, 1995. - 114 p.
-
-
-
-
3
-
-
32944457941
-
Tumor antigen expression in melanoma varies according to antigen and stage
-
Barrow C., Browning J., MacGregor D. et al. Tumor antigen expression in melanoma varies according to antigen and stage // Clin. Cancer Res. - 2006. - Vol. 12. - R 764-771.
-
(2006)
Clin. Cancer Res
, vol.12
, Issue.R
, pp. 764-771
-
-
Barrow, C.1
Browning, J.2
MacGregor, D.3
-
4
-
-
0037428757
-
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
-
P
-
Bernsen M.R., Hakansson L., Gustafsson B. et al. On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases // Brit. J. Cancer. - 2003. - Vol. 88. - P. 424-431.
-
(2003)
Brit. J. Cancer
, vol.88
, pp. 424-431
-
-
Bernsen, M.R.1
Hakansson, L.2
Gustafsson, B.3
-
5
-
-
0029924107
-
Human tumor antigens recognized by T lymphocytes
-
P
-
Boon T., van der Bruggen R Human tumor antigens recognized by T lymphocytes // J.Exp. Med. - 1996. - Vol. 183. - P. 725-729.
-
(1996)
J.Exp. Med
, vol.183
, pp. 725-729
-
-
Boon, T.1
van der Bruggen, R.2
-
6
-
-
0038620168
-
High levels of Fas ligand and MHC class Il in the absence of CD80 or CD86 expression and a decreased CD4+ T cell infiltration, enable murine skin tumours to progress
-
P
-
Byrne S.N., Halliday G.M. High levels of Fas ligand and MHC class Il in the absence of CD80 or CD86 expression and a decreased CD4+ T cell infiltration, enable murine skin tumours to progress // Cancer Immunol. Immunother. - 2003. - Vol. 52. - P. 396-402.
-
(2003)
Cancer Immunol. Immunother
, vol.52
, pp. 396-402
-
-
Byrne, S.N.1
Halliday, G.M.2
-
7
-
-
0035159576
-
Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: Implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group
-
P
-
de Vries T.J., Smeets M., de Graaf R. et al. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group // J. Pathol.-2001.-Vol. 193.-P. 13-20.
-
(2001)
J. Pathol
, vol.193
, pp. 13-20
-
-
de Vries, T.J.1
Smeets, M.2
de Graaf, R.3
-
8
-
-
0034980266
-
Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma
-
P
-
Dillman R.O., De Leon C., Beutel L.D. et al. Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma // Crit. Rev.Oncol.Hematol. - 2001. - Vol. 39. - P. 115-123.
-
(2001)
Crit. Rev.Oncol.Hematol
, vol.39
, pp. 115-123
-
-
Dillman, R.O.1
De Leon, C.2
Beutel, L.D.3
-
9
-
-
7244248962
-
Molecular detection of MART-1, tyrosinase and MIA in peripheral blood, lymph nodes and metastatic sites of stage III/IV melanoma patients
-
P
-
Enk C.D., Lotem M., Gimon Z. et al. Molecular detection of MART-1, tyrosinase and MIA in peripheral blood, lymph nodes and metastatic sites of stage III/IV melanoma patients // Melanoma Res. - 2004. - Vol. 14. - P. 361-365.
-
(2004)
Melanoma Res
, vol.14
, pp. 361-365
-
-
Enk, C.D.1
Lotem, M.2
Gimon, Z.3
-
10
-
-
47249120258
-
-
Freshney R.I. Culture of animal cells: A Manual of Basic Technique. - N. - Y - Chichester: Wiley&Sons, publ. - 2000.-577 p.
-
Freshney R.I. Culture of animal cells: A Manual of Basic Technique. - N. - Y - Chichester: Wiley&Sons, publ. - 2000.-577 p.
-
-
-
-
12
-
-
0029919132
-
Specificities and functions of CD4+ HLA class II-restricted T cell clones against a human sarcoma: Evidence for several recognized antigens
-
P
-
Heike M., Schlaak J., Schulze-Bergkamen H. et al. Specificities and functions of CD4+ HLA class II-restricted T cell clones against a human sarcoma: evidence for several recognized antigens // J. Immunol. - 1996. - Vol. 156. - P. 2205-2213.
-
(1996)
J. Immunol
, vol.156
, pp. 2205-2213
-
-
Heike, M.1
Schlaak, J.2
Schulze-Bergkamen, H.3
-
13
-
-
0141515613
-
A decrease in the expression of CD63 tetraspanin protein elevates invasive potential of human melanoma cells
-
P
-
Jang H.I., Lee H. A decrease in the expression of CD63 tetraspanin protein elevates invasive potential of human melanoma cells // Exp.Mol.Med. - 2003. - Vol. 35. - P. 317-323.
-
(2003)
Exp.Mol.Med
, vol.35
, pp. 317-323
-
-
Jang, H.I.1
Lee, H.2
-
14
-
-
0033034333
-
-
Kageshita T., Hirai S., Ono I et al. Down-regulation of HLA class | antigen-processing molecules in malignant Melanoma // Amer. J. Pathol. - 1999, - 154, - P. 745-754.
-
Kageshita T., Hirai S., Ono I et al. Down-regulation of HLA class | antigen-processing molecules in malignant Melanoma // Amer. J. Pathol. - 1999, - Vol. 154, - P. 745-754.
-
-
-
-
15
-
-
33750739534
-
HSP-70, C-myc and HLA-DR expression in patients with cutaneous malignant melanoma metastatic in lymph nodes
-
P
-
Kalogeraki A., Garbagnati F., Darivianaki K. et al. HSP-70, C-myc and HLA-DR expression in patients with cutaneous malignant melanoma metastatic in lymph nodes // Anticancer Res. - 2006. - Vol. 26. - P. 3551-3554.
-
(2006)
Anticancer Res
, vol.26
, pp. 3551-3554
-
-
Kalogeraki, A.1
Garbagnati, F.2
Darivianaki, K.3
-
16
-
-
2942683735
-
Gene expression signature, cancer cell evolution and metastatic progression
-
P
-
Klein C.A. Gene expression signature, cancer cell evolution and metastatic progression // Cell Cycle. - 2004. - Vol. 3.-P. 29-31.
-
(2004)
Cell Cycle
, vol.3
, pp. 29-31
-
-
Klein, C.A.1
-
17
-
-
0037965218
-
HLA II class expression in uveal melanoma: Correlation with clinicopathological features
-
P
-
Krishnakumar S., Abhyancar D., Lakshmi S.A. et al. HLA II class expression in uveal melanoma: correlation with clinicopathological features // Exp. Eye Res. - 2003, -Vol. 77. - P. 175-180.
-
(2003)
Exp. Eye Res
, vol.77
, pp. 175-180
-
-
Krishnakumar, S.1
Abhyancar, D.2
Lakshmi, S.A.3
-
18
-
-
0029078643
-
Detection of p53 mutation in benign and dysplastic nevi
-
P
-
Levin D.B., Wilson K., Valadares de Amorim G. et al. Detection of p53 mutation in benign and dysplastic nevi // Cancer Res. - 1995. - Vol. 55. - P. 4278-4282.
-
(1995)
Cancer Res
, vol.55
, pp. 4278-4282
-
-
Levin, D.B.1
Wilson, K.2
Valadares de Amorim, G.3
-
19
-
-
0035825042
-
-
Moingeon R Cancer vaccines // Vaccine. - 2001. - 19. - P. 1305-1326.
-
Moingeon R Cancer vaccines // Vaccine. - 2001. - Vol. 19. - P. 1305-1326.
-
-
-
-
22
-
-
0029061997
-
Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes
-
P
-
Rivoltini L., Barracchini K.C. Viggiano V. et al. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes // Cancer Res. - 1995. - Vol. 55. - P. 3149-3157.
-
(1995)
Cancer Res
, vol.55
, pp. 3149-3157
-
-
Rivoltini, L.1
Barracchini, K.C.2
Viggiano, V.3
-
23
-
-
0028363683
-
Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy
-
P
-
Robbins P.F., El-Gamil M., Kawakami Y., Rosenberg S.A. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy // Cancer Res. - 1994. - Vol. 54. - P. 3124-3126.
-
(1994)
Cancer Res
, vol.54
, pp. 3124-3126
-
-
Robbins, P.F.1
El-Gamil, M.2
Kawakami, Y.3
Rosenberg, S.A.4
-
24
-
-
0037111530
-
Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma
-
Robbins RF, El-Gamil M., Yong F.L. et al. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma // J. Immunol. - 2002. - Vol. 169. - R 6036-6047.
-
(2002)
J. Immunol
, vol.169
, Issue.R
, pp. 6036-6047
-
-
Robbins, R.F.1
El-Gamil, M.2
Yong, F.L.3
-
26
-
-
0038271868
-
From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression
-
P
-
Schmidt-Kittler O., Ragg T., Daskalakis A. et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression // PNAS (USA). - 2003. - Vol. 100. - P. 7737-7742.
-
(2003)
PNAS (USA)
, vol.100
, pp. 7737-7742
-
-
Schmidt-Kittler, O.1
Ragg, T.2
Daskalakis, A.3
-
27
-
-
0033627588
-
Vaccination against human cancers
-
P
-
Sinkovics J.C., Horvath J.C. Vaccination against human cancers // Int. J. Oncol. - 2000. - Vol. 16. - P. 81-96.
-
(2000)
Int. J. Oncol
, vol.16
, pp. 81-96
-
-
Sinkovics, J.C.1
Horvath, J.C.2
-
28
-
-
0037439963
-
Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas
-
P
-
Takeuchi H., Kuo C., Morton D.L. et al. Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas // Cancer Res. - 2003. - Vol. 63. - P. 441-448.
-
(2003)
Cancer Res
, vol.63
, pp. 441-448
-
-
Takeuchi, H.1
Kuo, C.2
Morton, D.L.3
-
29
-
-
0037341162
-
MAGE-6 encodes HLA-DRbeta 1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma
-
P
-
Tatsumi T., Kierstead L.S., Ranieri E. et al. MAGE-6 encodes HLA-DRbeta 1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma // Clin. Cancer Res - 2003. - Vol. 9. - P. 947-954.
-
(2003)
Clin. Cancer Res
, vol.9
, pp. 947-954
-
-
Tatsumi, T.1
Kierstead, L.S.2
Ranieri, E.3
-
30
-
-
84902414444
-
-
Taylor C.R., Shi S.R., Barr N.J., Wu N. Techniques of immunohistochemistry: principles, pitfalls and standardization // Diagnostic immunohistochemistry / Ed. Dabbs D. - Philadelphia: Elsevier Inc., 2006. - P. 1-43.
-
Taylor C.R., Shi S.R., Barr N.J., Wu N. Techniques of immunohistochemistry: principles, pitfalls and standardization // Diagnostic immunohistochemistry / Ed. Dabbs D. - Philadelphia: Elsevier Inc., 2006. - P. 1-43.
-
-
-
-
31
-
-
21244493998
-
Expression of melanoma-associated antigens in melanoma cell cultures
-
P
-
Urosevic M., Braun B., Willers J. et al. Expression of melanoma-associated antigens in melanoma cell cultures // Exp. Dermatol. - 2005. - Vol. 14. - P. 491-497.
-
(2005)
Exp. Dermatol
, vol.14
, pp. 491-497
-
-
Urosevic, M.1
Braun, B.2
Willers, J.3
-
32
-
-
0031472411
-
Tumor antigens discovery: Perspectives for cancer therapy
-
P
-
Wang R.F. Tumor antigens discovery: perspectives for cancer therapy // Mol.Med. - 1997. - Vol. 3. - P. 716-731.
-
(1997)
Mol.Med
, vol.3
, pp. 716-731
-
-
Wang, R.F.1
-
33
-
-
0037364292
-
Cancertestis-associated genes: Identification, expression profile, and putative function
-
P
-
Zendman A.J., Ruiter D.J., Van Muijen G.N. Cancertestis-associated genes: identification, expression profile, and putative function // J. Cell. Physiol. - 2003 - Vol. 194. - P. 272-288.
-
(2003)
J. Cell. Physiol
, vol.194
, pp. 272-288
-
-
Zendman, A.J.1
Ruiter, D.J.2
Van Muijen, G.N.3
-
34
-
-
1242342113
-
HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma
-
P
-
Zubovits J., Buzney E., Yu L., Duncan L.M. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma // Hum. Pathol. - 2004. - Vol. 35. - P. 217-223.
-
(2004)
Hum. Pathol
, vol.35
, pp. 217-223
-
-
Zubovits, J.1
Buzney, E.2
Yu, L.3
Duncan, L.M.4
|